1. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
   Yuanyuan Zhang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
2. Novel radiation and targeted therapy combinations for improving rectal cancer outcomes
   Kathryn Pennel et al, 2024, Expert Reviews in Molecular Medicine CrossRef
3. Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology
   Adrián Bazaga et al, 2020, Scientific Reports CrossRef
4. miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met
   Chun-Ming Huang et al, 2021, Biomedicines CrossRef
5. Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
   Zhengchao Zhang et al, 2022, Frontiers in Oncology CrossRef
6. A five‑gene based risk score with high prognostic value in colorectal cancer
   Yida Pan et al, 2017, Oncology Letters CrossRef
7. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
   Hongli Zhang et al, 2018, International Journal of Molecular Sciences CrossRef
8. Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met
   Qian-qian Liu et al, 2020, Journal of Zhejiang University-SCIENCE B CrossRef
9. The Prognostic Significance of c-Met and p53 Immunohistochemical Expression in Gastric and Colorectal Carcinomas
   Amany A. Abou-Bakr et al, 2021, Open Access Macedonian Journal of Medical Sciences CrossRef
10. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response
    Bettina Bohusné Barta et al, 2022, PLOS ONE CrossRef